Article
Heterophyllin B inhibits the malignant phenotypes of gastric cancer cells via CXCR4.
Human cell - 1 Mar 2023
Wei Yunhai, Yin Lei, Zhang Jinyu, Tang Jianing, Yu Xiaofeng, Wu Zhongxin, Gao Yuhai
Abstract excerpt
Heterophyllin B (HB) is a cyclic lipopeptide that has been shown to have anticancer effects. This study intended to further explore the effects and modulatory mechanism of HB in gastric cancer (GC) cells. The binding relationship between HB and CXCR4 was investigated by network pharmacological analysis, molecular docking, and cellular thermal shift assay (CETSA)-WB assay. Cellular assays revealed that HB could...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
